Delivery Order SPE2DB20D3111-SPE2DB23FA9AA

Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $3,523 delivery order to Amerisourcebergen Drug Corporation for 4562180583 HUMIRA(CF) 40 MG/0.4 ML syringes. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support the Defense Logistics Agency's medical supply needs. HUMIRA is a medication used to treat autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease. The delivery order was issued under an existing DLA contract...
The Defense Logistics Agency awarded a $4,034.08 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561343932 HUMIRA(CF) 40 MG/0.4 ML syringes. The firm fixed price order is being fulfilled from the contractor's Conshohocken, Pennsylvania location to support an unspecified DLA requirement. No major subcontractors or set aside designations were identified. HUMIRA is a rheumatoid arthritis and Crohn's disease treatment, suggesting this order supports DLA's medical supply chain...
The Defense Logistics Agency awarded a $1,187.61 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561401344 units of HUMIRA(CF) 40 MG/0.4 ML syringes. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning July 3, 2023 through July 5, 2023 to provide the requested pharmaceutical products in support of the Defense Logistics Agency's medical supply chain...
The Defense Logistics Agency awarded a $11,744.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561441577 units of HUMIRA 40 MG/0.8 ML SYRINGES. The contract has a period of performance from July 10, 2023 through July 11, 2023, with performance taking place in Conshohocken, Pennsylvania. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the rheumatoid arthritis drug HUMIRA supports the DLA's mission...
The Defense Logistics Agency Troop Support Medical awarded a $8,265 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561492037 units of HUMIRA 40 MG/0.8 ML SYRINGES. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 13-14, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply pharmaceutical products in support of...
The Defense Logistics Agency awarded a $7,075 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561949905 HUMIRA(CF) 40 MG/0.4 ML syringes. The syringes will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to support the Department of Defense's medical supply needs. As a leading pharmaceutical distributor, Amerisourcebergen will fulfill this order for the auto-injectable medication from August 25-28, 2023 without additional subcontractors....
The Defense Logistics Agency awarded a $1,761 firm fixed price delivery order to Amerisourcebergen Drug Corporation for HUMIRA(CF) PEN 40 MG/0.4 MLS syringes. The contract has a period of performance from August 3 to August 4, 2023, with all work to be conducted by the prime contractor in Conshohocken, Pennsylvania. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for the rheumatoid arthritis treatment HUMIRA supports the DLA's mission to...
The Defense Logistics Agency Troop Support Medical awarded a $32,750 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562100680 Humira 40 MG/0.8 ML syringes. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning September 8 through September 11, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and supply chain...
The Defense Logistics Agency awarded a $1,174 delivery order to Amerisourcebergen Drug Corporation for 4561421944 units of the pharmaceutical product HUMIRA(CF) 20 MG/0.2 ML SYRINGES. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania, with performance spanning July 6 through July 7, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for the rheumatoid arthritis treatment...
The Defense Logistics Agency Troop Support Medical awarded a $2,045.28 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 40 mg/0.4 ml syringes of HUMIRA(CF). Performance will take place in Conshohocken, Pennsylvania over a period of July 7-10, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corp, will serve as the prime contractor on this contract to supply the rheumatoid arthritis medication to the...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB23FA9AA
    Delivery Order

The Defense Logistics Agency awarded a $1,174 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561478529 HUMIRA 40 MG/0.8 ML SYRINGES. As the prime contractor, Amerisourcebergen will supply the human monoclonal antibody medication to treat autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is July 12-13, 2023. No major subcontractors or set aside designations were indicated. This order is likely in support of the DLA's medical supply chain responsibilities to equip U.S. military treatment facilities and beneficiaries.

Generated 12/15/23, 9:26 PM